India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
Select options
This product has multiple variants. The options may be chosen on the product page
Details
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
While most people chase AI stocks or compete for high‑pressure tech jobs, the real opportunity may be unfolding in AI boomtown real estate. As companies like OpenAI, Anthropic, Microsoft, and NVIDIA mint new waves of wealthy workers, demand for housing in key cities is exploding. From San Francisco to Austin, AI‑driven markets are seeing rising rents, limited inventory, and buyers preparing for massive IPO windfalls. For real estate professionals—or anyone entering the field—this surge represents one of the strongest long‑term opportunities in the industry.
Florida is ending its 1 percent emergency insurance surcharge two years ahead of schedule, saving homeowners an estimated 650 million dollars through 2028. Thanks to a calm hurricane season, fewer insurer failures, and reduced lawsuits, officials say the state’s property insurance market is now in its strongest financial position in a decade. The change offers relief for homeowners and new momentum for Florida’s real estate industry, where lower insurance costs can boost buyer confidence and support smoother transactions.
A growing political push to block institutional investors from buying single-family homes may sound like a pro-homeowner policy, but the data shows it could do the opposite. Younger and racially diverse renters rely heavily on single-family rentals as an affordable, stable alternative to buying—yet restricting investor participation would shrink this supply, pushing many families into overcrowded housing, motels, or homelessness. The real issue isn’t who buys the homes, but that America doesn’t have enough of them.
Zillow’s 2026 Agent Trends Survey reveals a major shift in what agents value most: technology that reduces mental drain. Nearly half of agents now use AI tools daily, yet most still juggle multiple platforms that sap their focus. Zillow’s upcoming unified platform, Zillow Pro, aims to streamline workflows and cut cognitive load. The survey also highlights key industry trends, including buyer financial literacy gaps, the importance of relationships for lead generation and the growing need for tech fluency among both new and seasoned real estate professionals.
Florida’s housing market is still surging, with luxury enclaves like Lake Buena Vista, Jupiter Island, and Golden Beach seeing massive six‑figure price jumps in just one year. Smaller towns such as Old Town, Cross City, and Hosford also posted steady gains, proving demand is rising statewide. For real estate professionals, these trends highlight where buyers are moving, where inventory is tight, and where future opportunities lie—making market literacy an essential advantage for anyone pursuing or expanding a career in Florida real estate.
Rhode Island is launching its sixth major housing reform package, aiming to boost affordability through zoning updates, lot splits, code changes, and the revival of single room occupancy and co‑living housing. With the state still recovering from years of underbuilding and soaring home prices, lawmakers hope these reforms will unlock new supply, ease pressure on renters and buyers, and create fresh opportunities for real estate professionals.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
